⚠️

Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.

Read our methodology →

Charlene ScottMD

Internal Medicine · Burlington, NC 27215

NPI: 1144399080

Share:

9

🟢 Low

Risk Flags

Opioid + benzodiazepine co-prescriber

Risk indicators are statistical patterns, not allegations. Learn more

8,661

Total Claims

$596K

Drug Cost

582

Beneficiaries

$1,023

Cost/Patient

Risk Score Breakdown 9/100

Low (0)Moderate (15)Elevated (30)High (50+)
Opioid + benzodiazepine combo+8

Score components are additive. Read full methodology

Peer Comparison vs. 110,156 Internal Medicine providers

-86%

Opioid rate vs peers

0.3% vs 2.2% avg

-27%

Cost per patient vs peers

$1,023 vs $1,411 avg

-9%

Brand preference vs peers

9.7% vs 10.6% avg

⚠️ Opioid + Benzodiazepine Co-Prescriber

This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.

🔎 Data Overview

⚠️

This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.

Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.

Opioid Prescribing

0.3%

Opioid Rate

27

Opioid Claims

$177

Opioid Cost

Long-Acting Rate

Brand vs Generic

90% generic

Brand: 835 claims · $469K

Generic: 7,777 claims · $122K

Top Prescribed Drugs

Drug (Generic)ClaimsCost
Empagliflozin124$113K
Apixaban89$75K
Semaglutide63$69K
Evolocumab39$37K
Dulaglutide16$28K
Tirzepatide16$17K
Alirocumab11$15K
Rosuvastatin Calcium851$14K
Liraglutide12$9,515
Levothyroxine Sodium448$8,015
Pantoprazole Sodium330$6,286
Insulin Degludec11$5,814
Losartan Potassium320$5,734
Omeprazole287$4,522
Telmisartan106$4,408

Prescribing Profile

104

Unique Drugs

$188K

IRA Negotiated Drugs

$123K

GLP-1 Drugs

9.0

Anomaly Score

Patient Profile

76

Avg Age

84%

Female

1.15

Avg Risk Score

Explore More

Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data